Pathstone Holdings
TNYA icon

Pathstone Holdings’s Tenaya Therapeutics TNYA Stock Holding History

Pathstone Holdings’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.4K Hold
75,000
– – ﹤0.01% 2307
2026
Q1 		$51.9K Hold
75,000
– – ﹤0.01% 2181
2025
Q4 		$53.4K Hold
75,000
– – ﹤0.01% 2186
2025
Q3 		$122K Hold
75,000
– – ﹤0.01% 2255
2025
Q2 		$45.8K Hold
75,000
– – ﹤0.01% 2148
2025
Q1 		$42.8K Buy
+75,000
New +$74K ﹤0.01% 2183

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pathstone Holdings's TNYA Position: Q2 2026 in Review

Pathstone Holdings held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 75,000 shares worth $55.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

Pathstone Holdings first reported a position in TNYA in Q1 2025 and has held it in 6 quarters since. The position peaked at $122K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Pathstone Holdings held 75,000 shares of Tenaya Therapeutics worth $55.4K as of Q2 2026.
  • Pathstone Holdings left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2307 holding.
  • Pathstone Holdings first reported a position in Tenaya Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Pathstone Holdings's Tenaya Therapeutics position peaked at $122K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.